BLPH
$3.25
Bellerophon Ther Com
($.12)
(3.56%)
BLPH
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.56)
Revenue:  $0.00 Mil
Monday
Feb 14
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BLPH reports earnings?
Beat
Meet
Miss

Where is BLPH's stock price going from here?
Up
Flat
Down
Stock chart of BLPH
Analysts
Summary of analysts' recommendations for BLPH
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company's product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton, New Jersey.
Peers
Vertex PharmaceuticalsUltragenyx PharmaceuticalRegeneron PharmaceuticalsBioMarin PharmaceuticalMerck & Co.ZoetisEli LillyBristol-Myers SquibbPfizerInterCept